Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment. Throughout the fourth quarter of 2022, Thermo Fisher expects to execute a $1.0 billion share repurchase program, bringing the total capital deployed on buybacks to $3.0 billion in 2022. Additionally, in a separate press release issued today, Thermo Fisher announced that it has entered into a definitive agreement to acq
Click here to view original post